← Insider Monitor
Arcus Biosciences, Inc. logo
RCUS

Arcus Biosciences, Inc.

NYSE · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Arcus Biosciences is a clinical-stage biopharmaceutical company that develops small-molecule and antibody-based therapies for cancer, including immunotherapies targeting pathways such as CD73, HIF-2α, and PD-1, often in combination regimens studied through partnerships with larger pharmaceutical companies.

Industry
Pharmaceutical Preparations
Headquarters
Hayward, CA
Exchange
NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Azoy AlexanderChief Accounting OfficerSell$85KAug 21, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for RCUS.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable RCUS activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.